Skip to main content
Clinical Trials/DRKS00014027
DRKS00014027
Recruiting
N/A

Biomarkers for predicting postoperative complications following anatomic lung resection - BNP

Abteilung für Thoraxchirurgie,Klinik Schillerhöhe,Robert-Bosch-KrankenhausProf. Dr. med. Godehard Friedel, Dr. med. Ruoyu Zhang0 sites400 target enrollmentMarch 2, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
In this prospective study we assess the predictive ability of B-type natriuretic peptide (BNP) and lactate for complications after anatomic lung rescection.
Sponsor
Abteilung für Thoraxchirurgie,Klinik Schillerhöhe,Robert-Bosch-KrankenhausProf. Dr. med. Godehard Friedel, Dr. med. Ruoyu Zhang
Enrollment
400
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 2, 2018
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Abteilung für Thoraxchirurgie,Klinik Schillerhöhe,Robert-Bosch-KrankenhausProf. Dr. med. Godehard Friedel, Dr. med. Ruoyu Zhang

Eligibility Criteria

Inclusion Criteria

  • Patients with confirmed or suspected lung cancer, who undergo anatomic lung resektion (pneumonectomy, lobectomy, Bi\-lobectomy or segmentectomy) as elective surgery.

Exclusion Criteria

  • 1\. Lack of willingness to participate or capacity for consent,
  • 2\. Urgent or emergency surgery,
  • 3\. Redo surgery,
  • 4\. Age \< 18,
  • 5\. Angina pectoris, myocardial infarction, pulmonary oedema, stroke or pneumonia in the last months.

Outcomes

Primary Outcomes

Not specified

Similar Trials